【市場調査レポート】末期腎疾患（ESRD）療法のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global End Stage Renal Disease (ESRD) Therapy Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。末期腎疾患（ESRD）療法のグローバル市場インサイト・予測（～2028年） / Global End Stage Renal Disease (ESRD) Therapy Market Insights, Forecast to 2028 / QY2207C3545資料のイメージです。

• レポートコード：QY2207C3545
• 出版社/出版日：QYResearch / 2022年7月11日
• レポート形態：英文、PDF、110ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の末期腎疾患（ESRD）療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に末期腎疾患（ESRD）療法の世界市場のxxx％を占める「血液透析」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の末期腎疾患（ESRD）療法の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの末期腎疾患（ESRD）療法市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの末期腎疾患（ESRD）療法市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

末期腎疾患（ESRD）療法のグローバル主要メーカーには、Fresenius、DaVita、Baxter、Nipro、B. Braun、Asahi Kasei、Nikkiso、WEGO、Newsol、Mayo Clinic、Guangdong Biolight、Medtronic、Sanxin Medtec、Jafron Biomedical、SWS Hemodialysis Care、Tianyi Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

末期腎疾患（ESRD）療法市場は、種類と用途によって区分されます。世界の末期腎疾患（ESRD）療法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
血液透析、腹膜透析、腎臓移植

【用途別セグメント】
病院、腎臓透析センター、家庭、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 末期腎疾患（ESRD）療法製品概要
- 種類別市場（血液透析、腹膜透析、腎臓移植）
- 用途別市場（病院、腎臓透析センター、家庭、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の末期腎疾患（ESRD）療法販売量予測2017-2028
- 世界の末期腎疾患（ESRD）療法売上予測2017-2028
- 末期腎疾患（ESRD）療法の地域別販売量
- 末期腎疾患（ESRD）療法の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別末期腎疾患（ESRD）療法販売量
- 主要メーカー別末期腎疾患（ESRD）療法売上
- 主要メーカー別末期腎疾患（ESRD）療法価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（血液透析、腹膜透析、腎臓移植）
- 末期腎疾患（ESRD）療法の種類別販売量
- 末期腎疾患（ESRD）療法の種類別売上
- 末期腎疾患（ESRD）療法の種類別価格
・用途別市場規模（病院、腎臓透析センター、家庭、その他）
- 末期腎疾患（ESRD）療法の用途別販売量
- 末期腎疾患（ESRD）療法の用途別売上
- 末期腎疾患（ESRD）療法の用途別価格
・北米市場
- 北米の末期腎疾患（ESRD）療法市場規模（種類別、用途別）
- 主要国別の末期腎疾患（ESRD）療法市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの末期腎疾患（ESRD）療法市場規模（種類別、用途別）
- 主要国別の末期腎疾患（ESRD）療法市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の末期腎疾患（ESRD）療法市場規模（種類別、用途別）
- 主要国別の末期腎疾患（ESRD）療法市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の末期腎疾患（ESRD）療法市場規模（種類別、用途別）
- 主要国別の末期腎疾患（ESRD）療法市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの末期腎疾患（ESRD）療法市場規模（種類別、用途別）
- 主要国別の末期腎疾患（ESRD）療法市場規模（トルコ、サウジアラビア）
・企業情報
Fresenius、DaVita、Baxter、Nipro、B. Braun、Asahi Kasei、Nikkiso、WEGO、Newsol、Mayo Clinic、Guangdong Biolight、Medtronic、Sanxin Medtec、Jafron Biomedical、SWS Hemodialysis Care、Tianyi Medical
・産業チェーン及び販売チャネル分析
- 末期腎疾患（ESRD）療法の産業チェーン分析
- 末期腎疾患（ESRD）療法の原材料
- 末期腎疾患（ESRD）療法の生産プロセス
- 末期腎疾患（ESRD）療法の販売及びマーケティング
- 末期腎疾患（ESRD）療法の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 末期腎疾患（ESRD）療法の産業動向
- 末期腎疾患（ESRD）療法のマーケットドライバー
- 末期腎疾患（ESRD）療法の課題
- 末期腎疾患（ESRD）療法の阻害要因
・主な調査結果

End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
Market Analysis and Insights: Global End Stage Renal Disease (ESRD) Therapy Market
The global End Stage Renal Disease (ESRD) Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Hemodialysis accounting for % of the End Stage Renal Disease (ESRD) Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China End Stage Renal Disease (ESRD) Therapy market size is valued at US$ million in 2021, while the North America and Europe End Stage Renal Disease (ESRD) Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe End Stage Renal Disease (ESRD) Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global End Stage Renal Disease (ESRD) Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global End Stage Renal Disease (ESRD) Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global End Stage Renal Disease (ESRD) Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global End Stage Renal Disease (ESRD) Therapy market.
Global End Stage Renal Disease (ESRD) Therapy Scope and Market Size
End Stage Renal Disease (ESRD) Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global End Stage Renal Disease (ESRD) Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Segment by Application
Hospitals
Kidney Dialysis Centers
At Homes
Others
By Company
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hemodialysis
1.2.3 Peritoneal Dialysis
1.2.4 Kidney Transplantation
1.3 Market by Application
1.3.1 Global End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Kidney Dialysis Centers
1.3.4 At Homes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global End Stage Renal Disease (ESRD) Therapy Market Perspective (2017-2028)
2.2 End Stage Renal Disease (ESRD) Therapy Growth Trends by Region
2.2.1 End Stage Renal Disease (ESRD) Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 End Stage Renal Disease (ESRD) Therapy Historic Market Size by Region (2017-2022)
2.2.3 End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Region (2023-2028)
2.3 End Stage Renal Disease (ESRD) Therapy Market Dynamics
2.3.1 End Stage Renal Disease (ESRD) Therapy Industry Trends
2.3.2 End Stage Renal Disease (ESRD) Therapy Market Drivers
2.3.3 End Stage Renal Disease (ESRD) Therapy Market Challenges
2.3.4 End Stage Renal Disease (ESRD) Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top End Stage Renal Disease (ESRD) Therapy Players by Revenue
3.1.1 Global Top End Stage Renal Disease (ESRD) Therapy Players by Revenue (2017-2022)
3.1.2 Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share by Players (2017-2022)
3.2 Global End Stage Renal Disease (ESRD) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by End Stage Renal Disease (ESRD) Therapy Revenue
3.4 Global End Stage Renal Disease (ESRD) Therapy Market Concentration Ratio
3.4.1 Global End Stage Renal Disease (ESRD) Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by End Stage Renal Disease (ESRD) Therapy Revenue in 2021
3.5 End Stage Renal Disease (ESRD) Therapy Key Players Head office and Area Served
3.6 Key Players End Stage Renal Disease (ESRD) Therapy Product Solution and Service
3.7 Date of Enter into End Stage Renal Disease (ESRD) Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 End Stage Renal Disease (ESRD) Therapy Breakdown Data by Type
4.1 Global End Stage Renal Disease (ESRD) Therapy Historic Market Size by Type (2017-2022)
4.2 Global End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Type (2023-2028)
5 End Stage Renal Disease (ESRD) Therapy Breakdown Data by Application
5.1 Global End Stage Renal Disease (ESRD) Therapy Historic Market Size by Application (2017-2022)
5.2 Global End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America End Stage Renal Disease (ESRD) Therapy Market Size (2017-2028)
6.2 North America End Stage Renal Disease (ESRD) Therapy Market Size by Type
6.2.1 North America End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022)
6.2.2 North America End Stage Renal Disease (ESRD) Therapy Market Size by Type (2023-2028)
6.2.3 North America End Stage Renal Disease (ESRD) Therapy Market Share by Type (2017-2028)
6.3 North America End Stage Renal Disease (ESRD) Therapy Market Size by Application
6.3.1 North America End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022)
6.3.2 North America End Stage Renal Disease (ESRD) Therapy Market Size by Application (2023-2028)
6.3.3 North America End Stage Renal Disease (ESRD) Therapy Market Share by Application (2017-2028)
6.4 North America End Stage Renal Disease (ESRD) Therapy Market Size by Country
6.4.1 North America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2017-2022)
6.4.2 North America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe End Stage Renal Disease (ESRD) Therapy Market Size (2017-2028)
7.2 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Type
7.2.1 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022)
7.2.2 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Type (2023-2028)
7.2.3 Europe End Stage Renal Disease (ESRD) Therapy Market Share by Type (2017-2028)
7.3 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Application
7.3.1 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022)
7.3.2 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Application (2023-2028)
7.3.3 Europe End Stage Renal Disease (ESRD) Therapy Market Share by Application (2017-2028)
7.4 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Country
7.4.1 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Country (2017-2022)
7.4.2 Europe End Stage Renal Disease (ESRD) Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size (2017-2028)
8.2 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Type
8.2.1 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Application
8.3.1 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Region
8.4.1 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America End Stage Renal Disease (ESRD) Therapy Market Size (2017-2028)
9.2 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Type
9.2.1 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022)
9.2.2 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Type (2023-2028)
9.2.3 Latin America End Stage Renal Disease (ESRD) Therapy Market Share by Type (2017-2028)
9.3 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Application
9.3.1 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022)
9.3.2 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Application (2023-2028)
9.3.3 Latin America End Stage Renal Disease (ESRD) Therapy Market Share by Application (2017-2028)
9.4 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Country
9.4.1 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2017-2022)
9.4.2 Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size (2017-2028)
10.2 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Type
10.2.1 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Application
10.3.1 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Country
10.4.1 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Fresenius
11.1.1 Fresenius Company Details
11.1.2 Fresenius Business Overview
11.1.3 Fresenius End Stage Renal Disease (ESRD) Therapy Introduction
11.1.4 Fresenius Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.1.5 Fresenius Recent Developments
11.2 DaVita
11.2.1 DaVita Company Details
11.2.2 DaVita Business Overview
11.2.3 DaVita End Stage Renal Disease (ESRD) Therapy Introduction
11.2.4 DaVita Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.2.5 DaVita Recent Developments
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter End Stage Renal Disease (ESRD) Therapy Introduction
11.3.4 Baxter Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.3.5 Baxter Recent Developments
11.4 Nipro
11.4.1 Nipro Company Details
11.4.2 Nipro Business Overview
11.4.3 Nipro End Stage Renal Disease (ESRD) Therapy Introduction
11.4.4 Nipro Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.4.5 Nipro Recent Developments
11.5 B. Braun
11.5.1 B. Braun Company Details
11.5.2 B. Braun Business Overview
11.5.3 B. Braun End Stage Renal Disease (ESRD) Therapy Introduction
11.5.4 B. Braun Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.5.5 B. Braun Recent Developments
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Details
11.6.2 Asahi Kasei Business Overview
11.6.3 Asahi Kasei End Stage Renal Disease (ESRD) Therapy Introduction
11.6.4 Asahi Kasei Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.6.5 Asahi Kasei Recent Developments
11.7 Nikkiso
11.7.1 Nikkiso Company Details
11.7.2 Nikkiso Business Overview
11.7.3 Nikkiso End Stage Renal Disease (ESRD) Therapy Introduction
11.7.4 Nikkiso Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.7.5 Nikkiso Recent Developments
11.8 WEGO
11.8.1 WEGO Company Details
11.8.2 WEGO Business Overview
11.8.3 WEGO End Stage Renal Disease (ESRD) Therapy Introduction
11.8.4 WEGO Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.8.5 WEGO Recent Developments
11.9 Newsol
11.9.1 Newsol Company Details
11.9.2 Newsol Business Overview
11.9.3 Newsol End Stage Renal Disease (ESRD) Therapy Introduction
11.9.4 Newsol Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.9.5 Newsol Recent Developments
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Details
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic End Stage Renal Disease (ESRD) Therapy Introduction
11.10.4 Mayo Clinic Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.10.5 Mayo Clinic Recent Developments
11.11 Guangdong Biolight
11.11.1 Guangdong Biolight Company Details
11.11.2 Guangdong Biolight Business Overview
11.11.3 Guangdong Biolight End Stage Renal Disease (ESRD) Therapy Introduction
11.11.4 Guangdong Biolight Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.11.5 Guangdong Biolight Recent Developments
11.12 Medtronic
11.12.1 Medtronic Company Details
11.12.2 Medtronic Business Overview
11.12.3 Medtronic End Stage Renal Disease (ESRD) Therapy Introduction
11.12.4 Medtronic Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.12.5 Medtronic Recent Developments
11.13 Sanxin Medtec
11.13.1 Sanxin Medtec Company Details
11.13.2 Sanxin Medtec Business Overview
11.13.3 Sanxin Medtec End Stage Renal Disease (ESRD) Therapy Introduction
11.13.4 Sanxin Medtec Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.13.5 Sanxin Medtec Recent Developments
11.14 Jafron Biomedical
11.14.1 Jafron Biomedical Company Details
11.14.2 Jafron Biomedical Business Overview
11.14.3 Jafron Biomedical End Stage Renal Disease (ESRD) Therapy Introduction
11.14.4 Jafron Biomedical Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.14.5 Jafron Biomedical Recent Developments
11.15 SWS Hemodialysis Care
11.15.1 SWS Hemodialysis Care Company Details
11.15.2 SWS Hemodialysis Care Business Overview
11.15.3 SWS Hemodialysis Care End Stage Renal Disease (ESRD) Therapy Introduction
11.15.4 SWS Hemodialysis Care Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.15.5 SWS Hemodialysis Care Recent Developments
11.16 Tianyi Medical
11.16.1 Tianyi Medical Company Details
11.16.2 Tianyi Medical Business Overview
11.16.3 Tianyi Medical End Stage Renal Disease (ESRD) Therapy Introduction
11.16.4 Tianyi Medical Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
11.16.5 Tianyi Medical Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Hemodialysis
Table 3. Key Players of Peritoneal Dialysis
Table 4. Key Players of Kidney Transplantation
Table 5. Global End Stage Renal Disease (ESRD) Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global End Stage Renal Disease (ESRD) Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global End Stage Renal Disease (ESRD) Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global End Stage Renal Disease (ESRD) Therapy Market Share by Region (2017-2022)
Table 9. Global End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global End Stage Renal Disease (ESRD) Therapy Market Share by Region (2023-2028)
Table 11. End Stage Renal Disease (ESRD) Therapy Market Trends
Table 12. End Stage Renal Disease (ESRD) Therapy Market Drivers
Table 13. End Stage Renal Disease (ESRD) Therapy Market Challenges
Table 14. End Stage Renal Disease (ESRD) Therapy Market Restraints
Table 15. Global End Stage Renal Disease (ESRD) Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global End Stage Renal Disease (ESRD) Therapy Revenue Share by Players (2017-2022)
Table 17. Global Top End Stage Renal Disease (ESRD) Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease (ESRD) Therapy as of 2021)
Table 18. Ranking of Global Top End Stage Renal Disease (ESRD) Therapy Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by End Stage Renal Disease (ESRD) Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players End Stage Renal Disease (ESRD) Therapy Product Solution and Service
Table 22. Date of Enter into End Stage Renal Disease (ESRD) Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share by Type (2017-2022)
Table 26. Global End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share by Type (2023-2028)
Table 28. Global End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global End Stage Renal Disease (ESRD) Therapy Revenue Share by Application (2017-2022)
Table 30. Global End Stage Renal Disease (ESRD) Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global End Stage Renal Disease (ESRD) Therapy Revenue Share by Application (2023-2028)
Table 32. North America End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America End Stage Renal Disease (ESRD) Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America End Stage Renal Disease (ESRD) Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe End Stage Renal Disease (ESRD) Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe End Stage Renal Disease (ESRD) Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe End Stage Renal Disease (ESRD) Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe End Stage Renal Disease (ESRD) Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific End Stage Renal Disease (ESRD) Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America End Stage Renal Disease (ESRD) Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa End Stage Renal Disease (ESRD) Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa End Stage Renal Disease (ESRD) Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa End Stage Renal Disease (ESRD) Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa End Stage Renal Disease (ESRD) Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa End Stage Renal Disease (ESRD) Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa End Stage Renal Disease (ESRD) Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 62. Fresenius Company Details
Table 63. Fresenius Business Overview
Table 64. Fresenius End Stage Renal Disease (ESRD) Therapy Product
Table 65. Fresenius Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 66. Fresenius Recent Developments
Table 67. DaVita Company Details
Table 68. DaVita Business Overview
Table 69. DaVita End Stage Renal Disease (ESRD) Therapy Product
Table 70. DaVita Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 71. DaVita Recent Developments
Table 72. Baxter Company Details
Table 73. Baxter Business Overview
Table 74. Baxter End Stage Renal Disease (ESRD) Therapy Product
Table 75. Baxter Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 76. Baxter Recent Developments
Table 77. Nipro Company Details
Table 78. Nipro Business Overview
Table 79. Nipro End Stage Renal Disease (ESRD) Therapy Product
Table 80. Nipro Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 81. Nipro Recent Developments
Table 82. B. Braun Company Details
Table 83. B. Braun Business Overview
Table 84. B. Braun End Stage Renal Disease (ESRD) Therapy Product
Table 85. B. Braun Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 86. B. Braun Recent Developments
Table 87. Asahi Kasei Company Details
Table 88. Asahi Kasei Business Overview
Table 89. Asahi Kasei End Stage Renal Disease (ESRD) Therapy Product
Table 90. Asahi Kasei Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 91. Asahi Kasei Recent Developments
Table 92. Nikkiso Company Details
Table 93. Nikkiso Business Overview
Table 94. Nikkiso End Stage Renal Disease (ESRD) Therapy Product
Table 95. Nikkiso Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 96. Nikkiso Recent Developments
Table 97. WEGO Company Details
Table 98. WEGO Business Overview
Table 99. WEGO End Stage Renal Disease (ESRD) Therapy Product
Table 100. WEGO Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 101. WEGO Recent Developments
Table 102. Newsol Company Details
Table 103. Newsol Business Overview
Table 104. Newsol End Stage Renal Disease (ESRD) Therapy Product
Table 105. Newsol Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 106. Newsol Recent Developments
Table 107. Mayo Clinic Company Details
Table 108. Mayo Clinic Business Overview
Table 109. Mayo Clinic End Stage Renal Disease (ESRD) Therapy Product
Table 110. Mayo Clinic Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 111. Mayo Clinic Recent Developments
Table 112. Guangdong Biolight Company Details
Table 113. Guangdong Biolight Business Overview
Table 114. Guangdong Biolight End Stage Renal Disease (ESRD) Therapy Product
Table 115. Guangdong Biolight Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 116. Guangdong Biolight Recent Developments
Table 117. Medtronic Company Details
Table 118. Medtronic Business Overview
Table 119. Medtronic End Stage Renal Disease (ESRD) Therapy Product
Table 120. Medtronic Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 121. Medtronic Recent Developments
Table 122. Sanxin Medtec Company Details
Table 123. Sanxin Medtec Business Overview
Table 124. Sanxin Medtec End Stage Renal Disease (ESRD) Therapy Product
Table 125. Sanxin Medtec Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 126. Sanxin Medtec Recent Developments
Table 127. Jafron Biomedical Company Details
Table 128. Jafron Biomedical Business Overview
Table 129. Jafron Biomedical End Stage Renal Disease (ESRD) Therapy Product
Table 130. Jafron Biomedical Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 131. Jafron Biomedical Recent Developments
Table 132. SWS Hemodialysis Care Company Details
Table 133. SWS Hemodialysis Care Business Overview
Table 134. SWS Hemodialysis Care End Stage Renal Disease (ESRD) Therapy Product
Table 135. SWS Hemodialysis Care Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 136. SWS Hemodialysis Care Recent Developments
Table 137. Tianyi Medical Company Details
Table 138. Tianyi Medical Business Overview
Table 139. Tianyi Medical End Stage Renal Disease (ESRD) Therapy Product
Table 140. Tianyi Medical Revenue in End Stage Renal Disease (ESRD) Therapy Business (2017-2022) & (US$ Million)
Table 141. Tianyi Medical Recent Developments
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global End Stage Renal Disease (ESRD) Therapy Market Share by Type: 2021 VS 2028
Figure 2. Hemodialysis Features
Figure 3. Peritoneal Dialysis Features
Figure 4. Kidney Transplantation Features
Figure 5. Global End Stage Renal Disease (ESRD) Therapy Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Kidney Dialysis Centers Case Studies
Figure 8. At Homes Case Studies
Figure 9. Others Case Studies
Figure 10. End Stage Renal Disease (ESRD) Therapy Report Years Considered
Figure 11. Global End Stage Renal Disease (ESRD) Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global End Stage Renal Disease (ESRD) Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global End Stage Renal Disease (ESRD) Therapy Market Share by Region: 2021 VS 2028
Figure 14. Global End Stage Renal Disease (ESRD) Therapy Market Share by Players in 2021
Figure 15. Global Top End Stage Renal Disease (ESRD) Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease (ESRD) Therapy as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by End Stage Renal Disease (ESRD) Therapy Revenue in 2021
Figure 17. North America End Stage Renal Disease (ESRD) Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America End Stage Renal Disease (ESRD) Therapy Market Size Market Share by Type (2017-2028)
Figure 19. North America End Stage Renal Disease (ESRD) Therapy Market Size Market Share by Application (2017-2028)
Figure 20. North America End Stage Renal Disease (ESRD) Therapy Market Size Share by Country (2017-2028)
Figure 21. United States End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe End Stage Renal Disease (ESRD) Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe End Stage Renal Disease (ESRD) Therapy Market Size Market Share by Type (2017-2028)
Figure 25. Europe End Stage Renal Disease (ESRD) Therapy Market Size Market Share by Application (2017-2028)
Figure 26. Europe End Stage Renal Disease (ESRD) Therapy Market Size Share by Country (2017-2028)
Figure 27. Germany End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific End Stage Renal Disease (ESRD) Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific End Stage Renal Disease (ESRD) Therapy Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific End Stage Renal Disease (ESRD) Therapy Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific End Stage Renal Disease (ESRD) Therapy Market Size Share by Region (2017-2028)
Figure 37. China End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America End Stage Renal Disease (ESRD) Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America End Stage Renal Disease (ESRD) Therapy Market Size Market Share by Type (2017-2028)
Figure 45. Latin America End Stage Renal Disease (ESRD) Therapy Market Size Market Share by Application (2017-2028)
Figure 46. Latin America End Stage Renal Disease (ESRD) Therapy Market Size Share by Country (2017-2028)
Figure 47. Mexico End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa End Stage Renal Disease (ESRD) Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa End Stage Renal Disease (ESRD) Therapy Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa End Stage Renal Disease (ESRD) Therapy Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa End Stage Renal Disease (ESRD) Therapy Market Size Share by Country (2017-2028)
Figure 53. Turkey End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE End Stage Renal Disease (ESRD) Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Fresenius Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 57. DaVita Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 58. Baxter Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 59. Nipro Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 60. B. Braun Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 61. Asahi Kasei Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 62. Nikkiso Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 63. WEGO Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 64. Newsol Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 65. Mayo Clinic Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 66. Guangdong Biolight Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 67. Medtronic Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 68. Sanxin Medtec Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 69. Jafron Biomedical Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 70. SWS Hemodialysis Care Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 71. Tianyi Medical Revenue Growth Rate in End Stage Renal Disease (ESRD) Therapy Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

末期腎疾患（ESRD）装置のグローバル市場インサイト・予測（～2028年）

Global End-Stage Renal Disease (ESRD) Device Market Insights, Forecast to 2028
QY2207C3559 2022年7月11日 109Pages
新型コロナウイルス感染症のパンデミックにより、世界の末期腎疾患（ESRD）装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に末期腎疾患...

世界の末期腎疾患（ESRD）デバイス市場予測（～2028年）：血液透析、腹膜透析、腎臓移植

Global End-Stage Renal Disease (ESRD) Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E7866 2022年5月 105Pages
末期腎疾患（ESRD）デバイス市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を...

がん光線力学療法のグローバル市場インサイト・予測（～2028年）

Global Cancer Photodynamic Therapy Market Insights, Forecast to 2028
QY2207C3467 2022年7月11日 109Pages
新型コロナウイルス感染症のパンデミックにより、世界のがん光線力学療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にがん光線力学療法の世...

エクソソーム療法のグローバル市場インサイト・予測（～2028年）

Global Exosome Therapy Market Insights, Forecast to 2028
QY2207C3823 2022年7月11日 108Pages
新型コロナウイルス感染症のパンデミックにより、世界のエクソソーム療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にエクソソーム療法の世...

カスタム配合療法のグローバル市場インサイト・予測（～2028年）

Global Custom Compounded Therapy Market Insights, Forecast to 2028
QY2207C3481 2022年7月11日 114Pages
新型コロナウイルス感染症のパンデミックにより、世界のカスタム配合療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカスタム配合療法の世...

末期腎疾患（ESRD）装置のグローバル市場インサイト・予測（～2028年） End-stage renal failure, also known as end-stage renal disease (ESRD), is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. There are three main methods of treatment：Hemodialysis,Kidney transpla…
世界の末期腎疾患（ESRD）デバイス市場予測（～2028年）：血液透析、腹膜透析、腎臓移植 The End-Stage Renal Disease (ESRD) Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
世界の腎透析装置市場予測（～2028年）：血液透析、腹膜透析 The Renal Dialysis Machines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
世界の腎臓病治療薬市場予測（～2028年）：錠剤、カプセル、その他 The Kidney Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
透析液フィルターのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Dialysis Fluid Filter Market Due to the COVID-19 pandemic, the global Dialysis Fluid Filter market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.…